A newsletter for those involved in clinical trials. Published 20 times a year by Canary Ltd

International trials

The following articles on this topic have been published in CRAdvisor (CRA) – the year, issue number and starting page number for each are listed below:

Back to index
2007  
CRA 2007; 186:7 New trials regulation in Peru.
CRA 2007; 186:7 China promises stricter measures.
CRA 2007; 186:8 India approves Central Drugs Authority.
CRA 2007; 188:2 FDA inspection findings in Russia and Eastern Europe.
CRA 2007; 193:1 China's former regulatory head sentenced to death.
CRA 2007; 193:4 Japanese regulations in English.
CRA 2007; 193:7 Ban on export of biological samples from Russia.
CRA 2007; 195:7 Biological samples and trials in Russia.
   
2006  
CRA 2006; 163:11 India reclassifies devices as drugs.
CRA 2006; 166:7 Is the Middle East set to become a major research region?
CRA 2006; 172:8 EFGCP seminar on trials in India.
CRA 2006; 173:4 Canada updates guidance on clinical trial records.
CRA 2006; 174:1 Russian GCP now in force.
CRA 2006; 175:3 Draft GCP guidelines published for Pan American region.
CRA 2006; 175:7 WHO Director-General.
CRA 2006; 175:7 WHO initiative to harmonise registration of clinical trials.
CRA 2006; 180:6 India's developing clinical research market.
CRA 2006; 181:8 Arrests after illegal human studies.
   
2005  
CRA 2005; 144:7 No plans by India to allow Phase I research.
CRA 2005; 149:8 New regulations in South America.
CRA 2005; 151:6 Quality conundrums: research in emerging regions - South Africa.
CRA 2005; 151:7 Argentina's new site inspections regulation.
CRA 2005; 151:7 New Brazilian trial regulations.
CRA 2005; 158:7 New regulatory body for India.
CRA 2005; 159:6 86% of trials are behind schedule: globalisation is a solution.
   
2004  
CRA 2004; 126:7 Brazil to reorganise adverse events reporting system.
CRA 2004; 128:2 Russia, Ukraine and the Balkans could solve patient recruitment problems.
CRA 2004; 130:4 VA officials charged with misuse of funds.
CRA 2004; 130:6 Guinea-pig soldiers to be compensated for chemical tests.
CRA 2004; 131:6 Expanding trial opportunities in Central and Eastern Europe.
CRA 2004; 134:7 New GMP certification in China.
CRA 2004; 134:7 Bioequivalence guidelines for India.
CRA 2004; 134:8 China to restrict sale of OTC antibiotics.
CRA 2004; 135:6 More FDA guidance on acceptability of foreign data.
CRA 2004; 136:1 Finding study sites able to meet today's subject recruitment demands.
CRA 2004; 136:3 Choosing new locations for clinical trials.
CRA 2004; 136:6 Operating in India.
CRA 2004; 136:9 Recruitment can be a major ethical problem in the less developed world.
CRA 2004; 136:11 FDA is changing attitude on the acceptability of foreign studies.
CRA 2004; 140:2 New WMA Secretary General appointed.
CRA 2004; 141:6  India announces legislation to make GCP compliance mandatory.
CRA 2004; 141:7 Clinical trial regulations in Norway.
CRA 2004; 142:12 Canada offers options for trials in North America.
   
2003  
CRA 2003; 103:3 Ethics and research in developing countries.
CRA 2003; 107:7 Problems in US healthcare system are worsening as medical litigation crisis deepens.
CRA 2003; 108:5 India: double standard for counterfeit drugs.
CRA 2003; 108:5 New Food and Drug Administration for China.
CRA 2003; 109:6 Encouraging pharmaceutical R&D in developing countries.
CRA 2003; 109:6 Singapore launches new standards for medical devices.
CRA 2003; 110:3 CEE countries are hot research sites; find out more at the ACRP Euro-Conference.
CRA 2003; 110:5 Conducting trials in India.
CRA 2003; 113:3 Italy's trial database provides useful information.
CRA 2003; 114:4 New developments relating to clinical research in South Africa.
CRA 2003; 117:7 Italy implements GCP Directive in law.
CRA 2003; 118:8 R & D in developing countries.
CRA 2003; 119:7 Regulatory requirements for trials in Romania.
CRA 2003; 119:8 Plumbing to blame for SARS.
CRA 2003; 119:8 MONICA results now available.
CRA 2003; 119:8 Global insulin shortage.
CRA 2003; 121:6 Russia's new regulation on pharmaceutical safety.
   
2002  
CRA 2002; 83:3 Pay attention to local legislation.
CRA 2002; 83:4 Canadian trial legislation revised.
CRA 2002; 91:8 Research and testing of AIDS vaccine for Africa needs scaling up and funding.
CRA 2002; 91:8 FIFA bags top health award.
CRA 2002; 95:3 Pharma facts - global drug sales grow.
   
2001  
CRA 2001; 62:6 Ethics timelines in The Netherlands.
CRA 2001; 64:4 International trials - are they performed ethically?
CRA 2001; 64:6 Counterfeits in China.
CRA 2001; 66:1 "Australians used as guinea-pigs for global drug market".
CRA 2001; 66:6 Licensing of herbal medicines.
CRA 2001; 72:7 Clinical trials in Latvia.
CRA 2001; 74:3 Reform for GP studies in Italy.
CRA 2001; 77:2 Argentina increases its role in clinical research.
CRA 2001; 80:3 Patient records system in Italy makes SDV difficult.
   
2000  
CRA 2000; 41:2 South African trials may be subject to new regulations.
CRA 2000; 50:6 Decline in clinical trials in Russia.
CRA 2000; 55:2 Clinical Trials in Central and Eastern Europe (CEE).
CRA 2000; 56:6 South Korean physicians strike.
   
1999  
CRA 1999; 19:5 Pre-trial requirements for the Baltic States.
CRA 1999; 19:6 Legislation for trials in Hungary.
CRA 1999; 21:1 Speed and data quality attract trials to CEE counties.
CRA 1999; 21:3 China as a clinical research site.
CRA 1999; 22:5 Consider Russia as a research site.
CRA 1999; 25:4 Consider Russia as a research site.
CRA 1999; 28:1 Trials multiply in Central and Eastern Europe.
CRA 1999; 29:3 Public believe researchers act from altruism.
CRA 1999; 30:5 Commencement of trials in EU Member States.
CRA 1999; 35:6 Scandal drug reborn.
CRA 1999; 36:4 How to be successful in developing countries.
   
1998  
CRA 1998; 18:1 Is Western Europe losing out on clinical trials?

Top